Single Dose Oral Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coated Tablets in Healthy Adult Human Subjects Under Fasting Conditions.

Clinical trial NCT06923956 · COMPLETED

Trial details

NCT number: NCT06923956
Sponsor: Humanis Saglık Anonim Sirketi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypercholesterolaemia Mixed Dyslipidaemia Cardiovascular Diseases

Start date: 2024-12-04
Primary completion: 2024-12-18
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.